Stay informed with the latest updates for the inheritable blood disorders community. IndustryPfizer Halts Development of HCV DrugApr 1, 2013 IndustryCSL's FXIII Product Approved for Expanded UseApr 1, 2013 IndustryCangene to Acquire IB1001 from InspirationMar 1, 2013 IndustryIdenix Ceases Development of Two HCV DrugsMar 1, 2013 IndustryGilead's HCV Therapy Trials On TrackMar 1, 2013 IndustryBiogen Reports A-LONG and B-LONG Studies ProgressMar 1, 2013 IndustryCSL Behring Enrolls Pediatric Patient in Hemophilia B StudyFeb 1, 2013 IndustryGreen Cross Initiates Phase III Trial of rFVIII ProductFeb 1, 2013 IndustryBaxter Announces Inhibitor Study Results, Acquisition of Inspiration…Feb 1, 2013 IndustryBiogen Idec Submits FDA Application for Long-Acting FIX TherapyFeb 1, 2013 MedicalInternational Study Finds Similar Inhibitor Risk for FVIII ProductsFeb 1, 2013 MedicalResearchers Discover Genetic Links to VWFFeb 1, 2013 MedicalNew Blood Center in PhiladelphiaFeb 1, 2013 IndustryBaxter Presents Data on Developmental Recombinant FIX ProductJan 1, 2013 MedicalLaser Therapy for Gum Disease Benefits Bleeding Disorders PatientsJan 1, 2013 Pagination First page Previous page … Page 35 Page 36 Page 37 Page 38 Current page 39 Page 40 Page 41 Page 42 Page 43 … Next page Last page